Macroview Investment Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-97	Closed	-$11.2K	–	366
2024 Q3	$11.2K	Buy	97 +74	+322%	+$10.1K	0.01%	220
2024 Q2	$3.17K	Hold	23	–	–	﹤0.01%	427
2024 Q1	$3.17K	Hold	23	–	–	﹤0.01%	467
2023 Q4	$3.03K	Sell	23 -73	-76%	-$8.4K	﹤0.01%	457
2023 Q3	$10.8K	Buy	96 +88	+1,100%	+$9.27K	0.01%	238
2023 Q2	$755	Hold	8	–	–	﹤0.01%	434
2023 Q1	$810	Sell	8 -105	-93%	-$10.9K	﹤0.01%	389
2022 Q4	$13.5K	Hold	113	–	–	0.02%	159
2022 Q3	$12K	Buy	113 +105	+1,313%	+$10.7K	0.02%	147
2022 Q2	$1K	Hold	8	–	–	﹤0.01%	405
2022 Q1	$1K	Hold	8	–	–	﹤0.01%	391
2021 Q4	$1K	Hold	8	–	–	﹤0.01%	359
2021 Q3	$1K	Hold	8	–	–	﹤0.01%	349
2021 Q2	$1K	Hold	8	–	–	﹤0.01%	375
2021 Q1	$1K	Hold	8	–	–	﹤0.01%	349
2020 Q4	$1K	Hold	8	–	–	﹤0.01%	324
2020 Q3	$1K	Buy	+8	New	+$925	﹤0.01%	299
2019 Q4	–	Sell	-37	Closed	-$3K	–	325
2019 Q3	$3K	Buy	+37	New	+$3.46K	0.01%	237